Comparison of the Performance of 6 Prognostic Signatures for Estrogen Receptor–Positive Breast Cancer: A Secondary Analysis of a Randomized Clinical Trial

IMPORTANCE: Multiple molecular signatures are available for managing estrogen receptor (ER)–positive breast cancer but with little direct comparative information to guide the patient’s choice. OBJECTIVE: To conduct a within-patient comparison of the prognostic value of 6 multigene signatures in wome...

Descripción completa

Detalles Bibliográficos
Autores principales: Sestak, Ivana, Buus, Richard, Cuzick, Jack, Dubsky, Peter, Kronenwett, Ralf, Denkert, Carsten, Ferree, Sean, Sgroi, Dennis, Schnabel, Catherine, Baehner, Frederick L., Mallon, Elizabeth, Dowsett, Mitch
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2018
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5885222/
https://www.ncbi.nlm.nih.gov/pubmed/29450494
http://dx.doi.org/10.1001/jamaoncol.2017.5524

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5885222/
https://www.ncbi.nlm.nih.gov/pubmed/29450494
http://dx.doi.org/10.1001/jamaoncol.2017.5524

Ejemplares similares